Skip to main content

Gestational Trophoblastic Tumors and Related Tumorlike Lesions

  • Living reference work entry
  • First Online:
Blaustein's Pathology of the Female Genital Tract

Abstract

Gestational trophoblastic disease (GTD) encompasses a heterogeneous group of lesions with specific clinical features, morphological characteristics, and pathogenesis. The World Health Organization classification of GTD includes complete and partial hydatidiform mole, invasive mole, choriocarcinoma, placental site trophoblastic tumor (PSTT), epithelioid trophoblastic tumor, exaggerated placental site, and placental site nodule (Table 1). Some of these lesions are true neoplasms, whereas others represent abnormally formed placentas with a predisposition for neoplastic transformation of the trophoblast. Two benign entities, the exaggerated placental site and the placental site nodule, are included because they are trophoblastic lesions that must be distinguished from other entities with malignant potential. The literature on GTD is extensive and at times confusing because of inconsistencies in classification and terminology. In fact, the necessity of a morphologic classification has been questioned, because current management is largely medical and in the case of trophoblastic disease following a mole, treatment is often conducted in the absence of a histological diagnosis. Thus, all trophoblastic lesions are frequently combined under the rubric of GTD without applying specific pathological terms. However, studies have demonstrated profound differences in the etiology, morphology, and clinical behavior of various forms of the disease. These studies underscore the importance of a uniform histological classification to facilitate standardized reporting of data and to ensure appropriate clinical management. Nonetheless, the term “GTD” has clinical utility, as the principles of human chorionic gonadotropin (hCG) monitoring in follow-up and the chemotherapy of metastatic or persistent disease are similar for all these entities.

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Institutional subscriptions

References

  • Altieri A et al (2003) Epidemiology and aetiology of gestational trophoblastic diseases. Lancet Oncol 4(11):670–678

    Article  PubMed  Google Scholar 

  • Aranake-Chrisinger J et al (2016) Use of short tandem repeat analysis in unusual presentations of trophoblastic tumors and their mimics. Hum Pathol 52:92–100

    Article  CAS  PubMed  Google Scholar 

  • Arroyo MR et al (2008) Placental site trophoblastic tumor in the ovary of a young child with isosexual precocious puberty. Pediatr Dev Pathol 12:73–76

    Article  Google Scholar 

  • Baergen RN, Rutgers J, Young RH (2003) Extrauterine lesions of intermediate trophoblast. Int J Gynecol Pathol 22(4):362–367

    Article  PubMed  Google Scholar 

  • Baergen RN et al (2006) Placental site trophoblastic tumor: a study of 55 cases and review of the literature emphasizing factors of prognostic significance. Gynecol Oncol 100(3):511–520

    Article  PubMed  Google Scholar 

  • Bagshawe KD et al (1990) Gestational trophoblastic tumours following initial diagnosis of partial hydatidiform mole. Lancet 335(8697):1074–1076

    Article  CAS  PubMed  Google Scholar 

  • Banet N et al (2013) Characteristics of hydatidiform moles: analysis of a prospective series with p57 immunohistochemistry and molecular genotyping. Mod Pathol 27:238

    Article  PubMed  CAS  Google Scholar 

  • Banet N et al (2015) GATA-3 expression in trophoblastic tissues: an immunohistochemical study of 445 cases, including diagnostic utility. Am J Surg Pathol 39(1):101–108

    Article  PubMed  PubMed Central  Google Scholar 

  • Berkowitz LW, Lage JM (1990) Persistent gestational trophoblastic tumor after partial hydatidiform mole. Gynecol Oncol 36:358–362

    Article  PubMed  Google Scholar 

  • Berkowitz RS et al (1998) Gestational trophoblastic disease. Subsequent pregnancy outcome, including repeat molar pregnancy. J Reprod Med 43(1):81–86

    CAS  PubMed  Google Scholar 

  • Bifulco C et al (2008) Genotypic analysis of hydatidiform mole: an accurate and practical method of diagnosis. Am J Surg Pathol 32(3):445–451

    Article  PubMed  Google Scholar 

  • Brown J et al (2017) 15years of progress in gestational trophoblastic disease: scoring, standardization, and salvage. Gynecol Oncol 144(1):200–207

    Article  PubMed  Google Scholar 

  • Burrows TD, King A, Loke YW (1994) Expression of adhesion molecules by endovascular trophoblast and decidual endothelial cells: implications for vascular invasion during implantation. Placenta 15(1):21–33

    Article  CAS  PubMed  Google Scholar 

  • Carinelli SG, Verdola N, Zanotti F (1989) Placental site nodule: a report of 17 cases. Pathol Res Pract 185:30–34

    Google Scholar 

  • Castrillon DH et al (2001) Discrimination of complete hydatidiform mole from its mimics by immunohistochemistry of the paternally imprinted gene product p57KIP2. Am J Surg Pathol 25(10):1225–1230

    Article  CAS  PubMed  Google Scholar 

  • Chang YL et al (1999) Prognostic factors and treatment for placental site trophoblastic tumor- report of 3 cases and analysis of 88 cases. Gynecol Oncol 73(2):216–222

    Article  CAS  PubMed  Google Scholar 

  • Cheung AN et al (1998) p21WAF1/CIP1 expression in gestational trophoblastic disease: correlation with clinicopathological parameters, and Ki67 and p53 gene expression. J Clin Pathol 51(2):159–162

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  • Chew SH et al (2000) Morphology and DNA content analysis in the evaluation of first trimester placentas for partial hydatidiform mole (PHM). Hum Pathol 31(8):914–924

    Article  CAS  PubMed  Google Scholar 

  • Chilosi M et al (1998) Differential expression of p57kip2, a maternally imprinted cdk inhibitor, in normal human placenta and gestational trophoblastic disease. Lab Investig 78(3):269–276

    CAS  PubMed  Google Scholar 

  • Cole LA (2009) New discoveries on the biology and detection of human chorionic gonadotropin. Reprod Biol Endocrinol 7(1):8

    Article  PubMed  PubMed Central  CAS  Google Scholar 

  • Cole LA et al (2006) Gestational trophoblastic diseases: 3. Human chorionic gonadotropin-free beta-subunit, a reliable marker of placental site trophoblastic tumors. Gynecol Oncol 102(2):160–164

    Article  CAS  PubMed  Google Scholar 

  • Cole KA et al (2008a) A functional screen identifies miR-34a as a candidate neuroblastoma tumor suppressor gene. Mol Cancer Res 6(5):735–742

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  • Cole ME et al (2008b) Placental-site trophoblastic tumors: a case of resistant pulmonary metastasis. Nat Clin Pract Oncol 5(3):171–175

    Article  PubMed  Google Scholar 

  • Coukos G et al (1999) Complete hydatidiform mole. A disease with a changing profile [In process citation]. J Reprod Med 44(8):698–704

    CAS  PubMed  Google Scholar 

  • Czernobilsky B, Barash A, Lancet M (1982) Partial moles: a clinicopathologic study of 25 cases. Obstet Gynecol 59:75–77

    CAS  PubMed  Google Scholar 

  • Davidson B, Baekelandt M, Shih IM (2007) MUC4 is upregulated in ovarian carcinoma effusions and differentiates carcinoma cells from mesothelial cells. Diagn Cytopathol 35(12):756–760

    Article  PubMed  Google Scholar 

  • Davis MR et al (2015) Epithelioid trophoblastic tumor: a single institution case series at the New England Trophoblastic Disease Center. Gynecol Oncol 137(3):456–461

    Article  CAS  PubMed  Google Scholar 

  • DeScipio C et al (2011) Diandric triploid hydatidiform mole with loss of maternal chromosome 11. Am J Surg Pathol 35(10):1586–1591

    Article  PubMed  Google Scholar 

  • Dotto J, Hui P (2008) Lack of genetic association between exaggerated placental site reaction and placental site trophoblastic tumor. Int J Gynecol Pathol 27(4):562–567

    Article  PubMed  Google Scholar 

  • Elston C (1995) Gestational trophoblastic disease. In: Fox H (ed) Haines and Taylor: textbook of obstetrical and gynecological pathology, 4th edn. Churchill Linvingstone, New York, pp 1597–1639

    Google Scholar 

  • Essel KG et al (2017) Salvage chemotherapy for gestational trophoblastic neoplasia: utility or futility? Gynecol Oncol 146(1):74–80

    Article  CAS  PubMed  Google Scholar 

  • Fadare O et al (2006) Epithelioid trophoblastic tumor: clinicopathological features with an emphasis on uterine cervical involvement. Mod Pathol 19(1):75–82

    Article  CAS  PubMed  Google Scholar 

  • Faes T et al (2012) Chorangiocarcinoma of the placenta: a case report and clinical review. Placenta 33(8):658–661

    Article  CAS  PubMed  Google Scholar 

  • Fisher RA et al (2014) Clinical utility of selective molecular genotyping for diagnosis of partial hydatidiform mole; a retrospective study from a regional trophoblastic disease unit. J Clin Pathol 67(11):980–984

    Article  PubMed  Google Scholar 

  • Folberg R, Hendrix MJ, Maniotis AJ (2000) Vasculogenic mimicry and tumor angiogenesis. Am J Pathol 156(2):361–381

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  • Garg R et al (2004) Have you ruled out a placental site nodule? Contempory OB/Gyn 49:18–20

    Google Scholar 

  • Garner EI et al (2007) Gestational trophoblastic disease. Clin Obstet Gynecol 50(1):112–122

    Article  PubMed  Google Scholar 

  • Genest DR (2001) Partial hydatidiform mole: clinicopathological features, differential diagnosis, ploidy and molecular studies, and gold standards for diagnosis. Int J Gynecol Pathol 20(4):315–322

    Article  CAS  PubMed  Google Scholar 

  • Giordano G et al (2016) A case of placental site nodule associated with cervical high-grade squamous intraepithelial lesion. Eur J Gynaecol Oncol 37(2):259–261

    CAS  PubMed  Google Scholar 

  • Golfier F et al (2007) First epidemiological data from the French Trophoblastic Disease Reference Center. Am J Obstet Gynecol 196(2):172 e1–172 e5

    Article  Google Scholar 

  • Golubovsky MD (2003) Postzygotic diploidization of triploids as a source of unusual cases of mosaicism, chimerism and twinning. Hum Reprod 18(2):236–242

    Article  CAS  PubMed  Google Scholar 

  • Goto S et al (1993) Development of postmolar trophoblastic disease after partial molar pregnancy. Gynecol Oncol 48(2):165–170

    Article  CAS  PubMed  Google Scholar 

  • Gupta M et al (2012) Diagnostic reproducibility of hydatidiform moles: ancillary techniques (p57 immunohistochemistry and molecular genotyping) improve morphologic diagnosis for both recently trained and experienced gynecologic pathologists. Am J Surg Pathol 36(12):1747–1760

    Article  PubMed  PubMed Central  Google Scholar 

  • Gupta M et al (2017) Extrauterine placental site trophoblastic tumor involving the vagina. Int J Gynecol Pathol 36(3):294–299

    Article  CAS  PubMed  Google Scholar 

  • Hamazaki S et al (1999) Epithelioid trophoblastic tumor: morphological and immunohistochemical study of three lung lesions. Hum Pathol 30:1321–1327

    Article  CAS  PubMed  Google Scholar 

  • Hancock BW, Nazir K, Everard JE (2006) Persistent gestational trophoblastic neoplasia after partial hydatidiform mole incidence and outcome. J Reprod Med 51(10):764–766

    PubMed  Google Scholar 

  • Hando T, Ohno M, Kurose T (1998) Recent aspects of gestational trophoblastic disease in Japan. Int J Gynaecol Obstet 60(Suppl 1):S71–S76

    Article  PubMed  Google Scholar 

  • Harvey RA et al (2008) Human chorionic gonadotropin free beta-subunit measurement as a marker of placental site trophoblastic tumors. J Reprod Med 53(8):643–648

    CAS  PubMed  Google Scholar 

  • Hassadia A et al (2005) Placental site trophoblastic tumour: clinical features and management. Gynecol Oncol 99(3):603–607

    Article  PubMed  Google Scholar 

  • Hernandez L et al (2003) Paternal and maternal genomes confer opposite effects on proliferation, cell-cycle length, senescence, and tumor formation. Proc Natl Acad Sci U S A 100(23):13344–13349

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  • Hoekstra AV, Keh P, Lurain JR (2004) Placental site trophoblastic tumor: a review of 7 cases and their implications for prognosis and treatment. J Reprod Med 49(6):447–452

    PubMed  Google Scholar 

  • Horowitz NS, Goldstein DP, Berkowitz RS (2017) Placental site trophoblastic tumors and epithelioid trophoblastic tumors: biology, natural history, and treatment modalities. Gynecol Oncol 144(1):208–214

    Article  PubMed  Google Scholar 

  • How J et al (1995) Placental site trophoblastic tumor. Report of three cases and review of the literature. Int J Gynecol Cancer 5:241–249

    Article  PubMed  Google Scholar 

  • Hsieh TY et al (2008) Uterine choriocarcinoma accompanied by an extremely high human chorionic gonadotropin level and thyrotoxicosis. J Obstet Gynaecol Res 34(2):274–278

    Article  PubMed  Google Scholar 

  • Huang B et al (2015) Chorangiocarcinoma: a case report and clinical review. Int J Clin Exp Med 8(9):16798–16802

    PubMed  PubMed Central  Google Scholar 

  • Huettner PC, Gersell DJ (1994) Placental site nodule: a clinicopathologic study of 38 cases. Int J Gynecol Pathol 13(3):191–198

    Article  CAS  PubMed  Google Scholar 

  • Hui P et al (2000) Pathogenesis of placental site trophoblastic tumor may require the presence of a paternally derived X chromosome. Lab Investig 80(6):965–972

    Article  CAS  PubMed  Google Scholar 

  • Hui P et al (2004) Comparative genomic hybridization study of placental site trophoblastic tumour: a report of four cases. Mod Pathol 17(2):248–251

    Article  CAS  PubMed  Google Scholar 

  • Hui P et al (2017) Hydatidiform moles: genetic basis and precision diagnosis. Annu Rev Pathol 12:449–485

    Article  CAS  PubMed  Google Scholar 

  • Jacobs PA et al (1982) Complete and partial hydatidiform mole in Hawaii: cytogenetics, morphology and epidemiology. Br J Obstet Gynaecol 89(4):258–266

    Article  CAS  PubMed  Google Scholar 

  • Jacques SM et al (1997) Retained trophoblastic tissue in fallopian tubes: a consequence of unsuspected ectopic pregnancies. Int J Gynecol Pathol 16(3):219–224

    Article  CAS  PubMed  Google Scholar 

  • Jauniaux E (1999) Partial moles: from postnatal to prenatal diagnosis. Placenta 20(5–6):379–388

    Article  CAS  PubMed  Google Scholar 

  • Jiao L et al (2016) Intraplacental choriocarcinoma: systematic review and management guidance. Gynecol Oncol 141(3):624–631

    Article  CAS  PubMed  Google Scholar 

  • Jones WB et al (1993) Thoracotomy in the management of gestational choriocarcinoma. A clinicopathologic study. Cancer 72(7):2175–2181

    Article  CAS  PubMed  Google Scholar 

  • Kalhor N et al (2009) Immunohistochemical studies of trophoblastic tumors. Am J Surg Pathol 33:633–638

    Article  PubMed  Google Scholar 

  • Kaur B et al (2015) Atypical placental site nodule (APSN) and association with malignant gestational trophoblastic disease; a clinicopathologic study of 21 cases. Int J Gynecol Pathol 34(2):152–158

    Article  PubMed  Google Scholar 

  • Keep D et al (1996) Very early complete hydatidiform mole. Hum Pathol 27(7):708–713

    Article  CAS  PubMed  Google Scholar 

  • Kerkmeijer LG et al (2009) Earlier diagnosis and serum human chorionic gonadotropin regression in complete hydatidiform moles. Obstet Gynecol 113(2 Pt 1):326–331

    Article  CAS  PubMed  Google Scholar 

  • Khong TY (2000) Chorangioma with trophoblastic proliferation. Virchows Arch 436(2):167–171

    Article  CAS  PubMed  Google Scholar 

  • Kim JH et al (1998) Subsequent reproductive experience after treatment for gestational trophoblastic disease. Gynecol Oncol 71(1):108–112

    Article  CAS  PubMed  Google Scholar 

  • Kim SY, Chang AS, Ratts VS (2005) Radiographic and hysteroscopic findings of a placental site nodule. Fertil Steril 83(1):213–215

    Article  PubMed  Google Scholar 

  • Kim MJ et al (2006) Diagnostic and pathogenetic significance of increased stromal apoptosis and incomplete vasculogenesis in complete hydatidiform moles in very early pregnancy periods. Am J Surg Pathol 30(3):362–369

    Article  CAS  PubMed  Google Scholar 

  • Kurek C, Jaworski R, Lamaro V (2017) Extrauterine peritoneal placental site nodule. Pathology 49(5):560–561

    Article  PubMed  Google Scholar 

  • Kurman RJ (1991) The morphology, biology, and pathology of intermediate trophoblast: a look back to the present. Hum Pathol 22(9):847–855

    Article  CAS  PubMed  Google Scholar 

  • Kurman RJ, Shih IM (2014) Discovery of a cell: reflections on the checkered history of intermediate trophoblast and update on its nature and pathologic manifestations. Int J Gynecol Pathol 33(4):339–347

    Article  PubMed  PubMed Central  Google Scholar 

  • Kurman RJ, Scully RE, Norris HJ (1976) Trophoblastic pseudotumor of the uterus: an exaggerated form of “syncytial endometritis” simulating a malignant tumor. Cancer 38(3):1214–1226

    Article  CAS  PubMed  Google Scholar 

  • Kurman RJ et al (1984) Immunocytochemical localization of placental lactogen and chorionic gonadotropin in the normal placenta and trophoblastic tumors, with emphasis on intermediate trophoblast and the placental site trophoblastic tumor. Int J Gynecol Pathol 3(1):101–121

    Article  CAS  PubMed  Google Scholar 

  • Lage JM et al (1992) A flow cytometric study of 137 fresh hydropic placentas: correlation between types of hydatidiform moles and nuclear DNA ploidy. Obstet Gynecol 79(3):403–410

    Article  CAS  PubMed  Google Scholar 

  • Lee KR et al (2003) Tumors of the oary and peritoneum- surface epithelial-stromal tumors. In: Tavassoli FA, Devilee P (eds) Pathology and genetics: tumors of the breast and female genital organs. IARC Press, Lyon, pp 113–202

    Google Scholar 

  • Lee Y et al (2007) A unifying concept of trophoblastic differentiation and malignancy defined by biomarker expression. Hum Pathol 38(7):1003–1013

    Article  CAS  PubMed  Google Scholar 

  • Li HW, Tsao SW, Cheung AN (2002) Current understandings of the molecular genetics of gestational trophoblastic diseases. Placenta 23(1):20–31

    Article  PubMed  Google Scholar 

  • Lipata F et al (2010) Precise DNA genotyping diagnosis of hydatidiform mole. Obstet Gynecol 115(4):784–794

    Article  PubMed  Google Scholar 

  • Macdonald MC et al (2008) Diagnostic challenges in extrauterine epithelioid trophoblastic tumours: a report of two cases. Gynecol Oncol 108(2):452–454

    Article  CAS  PubMed  Google Scholar 

  • Machtinger R et al (2005) Placental site trophoblastic tumor: outcome of five cases including fertility preserving management. Gynecol Oncol 96(1):56–61

    Article  PubMed  Google Scholar 

  • Mao TL et al (2006) Cyclin E and p16 immunoreactivity in epithelioid trophoblastic tumor – an aid in differential diagnosis. Am J Surg Pathol 30(9):1105–1110

    Article  PubMed  Google Scholar 

  • Mao TL et al (2007) Immunohistochemistry of choriocarcinoma: an aid in differential diagnosis and in elucidating pathogenesis. Am J Surg Pathol 31:1726–1732

    Article  PubMed  Google Scholar 

  • Mao TL et al (2008) HSD3B1 as a novel trophoblast-associated marker that assists in the differential diagnosis of trophoblastic tumors and tumorlike lesions. Am J Surg Pathol 32(2):236–242

    Article  PubMed  Google Scholar 

  • Matsui H, Iizuka Y, Sekiya S (1996) Incidence of invasive mole and choriocarcinoma following partial hydatidiform mole. Int J Gynaecol Obstet 53(1):63–64

    Article  CAS  PubMed  Google Scholar 

  • Mazur MT (1989) Metastatic gestational choriocarcinoma. Unusual pathologic variant following therapy. Cancer 63(7):1370–1377

    Article  CAS  PubMed  Google Scholar 

  • McCarthy WA et al (2017a) Atypical placental site nodule arising in a postcesarean section scar: case report and review of the literature. Int J Gynecol Pathol. PMID: 29140877, https://doi.org/10.1097/PGP.0000000000000468

  • McCarthy WA et al (2017b) Comparison of p63 and p40 Immunohistochemical stains to distinguish epithelioid trophoblastic tumor from other trophoblastic lesions. Int J Gynecol Pathol

    Google Scholar 

  • McConnell TG et al (2009a) Diagnosis and subclassification of hydatidiform moles using p57 immunohistochemistry and molecular genotyping: validation and prospective analysis in routine and consultation practice settings with development of an algorithmic approach. Am J Surg Pathol 33:805–817

    Article  PubMed  Google Scholar 

  • McConnell TG et al (2009b) Complete hydatidiform mole with retained maternal chromosomes 6 and 11. Am J Surg Pathol 33(9):1409–1415

    Article  PubMed  Google Scholar 

  • Menczer J et al (1999) Metastatic trophoblastic disease following partial hydatidiform mole: case report and literature review. Gynecol Oncol 74(2):304–307

    Article  CAS  PubMed  Google Scholar 

  • Milingos D et al (2007) Placental site trophoblastic tumor with an ovarian metastasis. Int J Gynecol Cancer 17(4):925–927

    Article  CAS  PubMed  Google Scholar 

  • Montes M et al (1996) Prevalence and significance of implantation site trophoblastic atypia in hydatidiform moles and spontaneous abortions. Am J Clin Pathol 105(4):411–416

    Article  CAS  PubMed  Google Scholar 

  • Moore-Maxwell CA, Robboy SJ (2004) Placental site trophoblastic tumor arising from antecedent molar pregnancy. Gynecol Oncol 92(2):708–712

    Article  PubMed  Google Scholar 

  • Morgan JM, Lurain JR (2008) Gestational trophoblastic neoplasia: an update. Curr Oncol Rep 10(6):497–504

    Article  PubMed  Google Scholar 

  • Mosher R et al (1998) Complete hydatidiform mole. Comparison of clinicopathologic features, current and past. J Reprod Med 43(1):21–27

    CAS  PubMed  Google Scholar 

  • Murdoch S et al (2006) Mutations in NALP7 cause recurrent hydatidiform moles and reproductive wastage in humans. Nat Genet 38(3):300–302

    Article  CAS  PubMed  Google Scholar 

  • Murphy KM et al (2012) Tetraploid partial hydatidiform mole: a case report and review of the literature. Int J Gynecol Pathol 31(1):73–79

    Article  PubMed  Google Scholar 

  • Nagai Y et al (2007) Impact of p53 immunostaining in predicting advanced or recurrent placental site trophoblastic tumors: a study of 12 cases. Gynecol Oncol 106(3):446–452

    Article  CAS  PubMed  Google Scholar 

  • Narita F et al (2003) Epithelioid trophoblastic tumor (ETT) initially interpreted as cervical cancer. Int J Gynecol Cancer 13(4):551–554

    Article  CAS  PubMed  Google Scholar 

  • Nayar R et al (1996) Placental site nodule occurring in a fallopian tube. Hum Pathol 27(11):1243–1245

    Article  CAS  PubMed  Google Scholar 

  • Newlands ES et al (2000) Etoposide and cisplatin/etoposide, methotrexate, and actinomycin D (EMA) chemotherapy for patients with high-risk gestational trophoblastic tumors refractory to EMA/cyclophosphamide and vincristine chemotherapy and patients presenting with metastatic placental site trophoblastic tumors. J Clin Oncol 18(4):854–859

    Article  CAS  PubMed  Google Scholar 

  • Ngan S, Seckl MJ (2007) Gestational trophoblastic neoplasia management: an update. Curr Opin Oncol 19(5):486–491

    Article  PubMed  Google Scholar 

  • Niemann I, Hansen ES, Sunde L (2007) The risk of persistent trophoblastic disease after hydatidiform mole classified by morphology and ploidy. Gynecol Oncol 104(2):411–415

    Article  PubMed  Google Scholar 

  • Nugent D et al (2006) Postpartum choriocarcinoma presentation, management and survival. J Reprod Med 51(10):819–824

    PubMed  Google Scholar 

  • Numnum TM et al (2006) Fertility sparing therapy in a patient with placental site trophoblastic tumor: a case report. Gynecol Oncol 103(3):1141–1143

    Article  PubMed  Google Scholar 

  • Oldt RJ 3rd, Kurman RJ, Shih IM (2002) Molecular genetic analysis of placental site trophoblastic tumors and epithelioid trophoblastic tumors confirms their trophoblastic origin. Am J Pathol 161(3):1033–1037

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  • Olsen JH et al (1999) Molar pregnancy and risk for cancer in women and their male partners. Am J Obstet Gynecol 181(3):630–634

    Article  CAS  PubMed  Google Scholar 

  • Palmer JR (1994) Advances in the epidemiology of gestational trophoblastic disease. J Reprod Med 39(3):155–162

    CAS  PubMed  Google Scholar 

  • Palmer JE et al (2008) Epithelioid trophoblastic tumor: a review of the literature. J Reprod Med 53(7):465–475

    CAS  PubMed  Google Scholar 

  • Papadopoulos AJ et al (2002) Twenty-five years’ clinical experience with placental site trophoblastic tumors. J Reprod Med 47(6):460–464

    PubMed  Google Scholar 

  • Parry DA et al (2011) Mutations causing familial biparental hydatidiform mole implicate c6orf221 as a possible regulator of genomic imprinting in the human oocyte. Am J Hum Genet 89(3):451–458

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  • Patten DK et al (2008) Gestational choriocarcinoma mimicking a uterine adenocarcinoma. J Clin Oncol 26(31):5126–5127

    Article  PubMed  Google Scholar 

  • Pfeffer PE et al (2007) Fertility-sparing partial hysterectomy for placental-site trophoblastic tumour. Lancet Oncol 8(8):744–746

    Article  PubMed  Google Scholar 

  • Piura B (2006) Placental site trophoblastic tumor – a challenging rare entity. Eur J Gynaecol Oncol 27(6):545–551

    CAS  PubMed  Google Scholar 

  • Piura B et al (2007) Placental site trophoblastic tumor: report of four cases and review of literature. Int J Gynecol Cancer 17(1):258–262

    Article  CAS  PubMed  Google Scholar 

  • Pluschke A et al (2014) Epithelioid trophoblastic tumour simulating a high grade carcinoma. Pathology 46(3):248–250

    Article  PubMed  Google Scholar 

  • Popiolek DA et al (2006) Multiplex short tandem repeat DNA analysis confirms the accuracy of p57(KIP2) immunostaining in the diagnosis of complete hydatidiform mole. Hum Pathol 37(11):1426–1434

    Article  CAS  PubMed  Google Scholar 

  • Redline RW, Hassold T, Zaragoza MV (1998) Prevalence of the partial molar phenotype in triploidy of maternal and paternal origin. Hum Pathol 29(5):505–511

    Article  CAS  PubMed  Google Scholar 

  • Rinne K, Shahabi S, Cole L (1999) Following metastatic placental site trophoblastic tumor with urine β-core fragment. Gynecol Oncol 74:302–303

    Article  CAS  PubMed  Google Scholar 

  • Ronnett BM, DeScipio C, Murphy KM (2011) Hydatidiform moles: ancillary techniques to refine diagnosis. Int J Gynecol Pathol 30(2):101–116

    Article  PubMed  Google Scholar 

  • Savage J et al (2017) Choriocarcinoma in women: analysis of a case series with genotyping. Am J Surg Pathol 41(12):1593–1606

    Article  PubMed  Google Scholar 

  • Seckl MJ et al (2000) Choriocarcinoma and partial hydatidiform moles. Lancet 356:36–39

    Article  CAS  PubMed  Google Scholar 

  • Sharkey AM et al (1999) Localization of leukemia inhibitory factor and its receptor in human placenta throughout pregnancy. Biol Reprod 60:355–364

    Article  CAS  PubMed  Google Scholar 

  • Shih IM (1999) The role of CD146 (Mel-CAM) in biology and pathology. J Pathol 189(1):4–11

    Article  CAS  PubMed  Google Scholar 

  • Shih IM (2007a) Gestational trophoblastic neoplasia – pathogenesis and potential therapeutic targets. Lancet Oncol 8(7):642–650

    Article  CAS  PubMed  Google Scholar 

  • Shih I-M (2007b) Trophogram, an immunohistochemistry-based algorithmic approach, in the differential diagnosis of trophoblastic tumors and tumorlike lesions. Ann Diagn Pathol 11(3):228–234

    Article  PubMed  Google Scholar 

  • Shih IM (2009) Gestational trophoblastic lesions. In: Oliva E, Nucci MR (eds) Gynecologic pathology. Churchill Livingstone Elsevier, New York, pp 645–665

    Chapter  Google Scholar 

  • Shih IM, Kuo KT (2008) Power of the eternal youth: Nanog expression in the gestational choriocarcinoma. Am J Pathol 173(4):911–914

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  • Shih IM, Kurman RJ (1996) Expression of melanoma cell adhesion molecule in intermediate trophoblast. Lab Investig 75(3):377–388

    CAS  PubMed  Google Scholar 

  • Shih IM, Kurman RJ (1998a) Ki-67 labeling index in the differential diagnosis of exaggerated placental site, placental site trophoblastic tumor, and choriocarcinoma: a double immunohistochemical staining technique using Ki-67 and Mel-CAM antibodies. Hum Pathol 29(1):27–33

    Article  CAS  PubMed  Google Scholar 

  • Shih I-M, Kurman RJ (1998b) Epithelioid trophoblastic tumor- a neoplasm distinct from choriocarcinoma and placental site trophoblastic tumor simulating carcinoma. Am J Surg Pathol 22(11):1393–1403

    Article  CAS  PubMed  Google Scholar 

  • Shih IM, Kurman RJ (1999) Immunohistochemical localization of inhibin-alpha in the placenta and gestational trophoblastic lesions. Int J Gynecol Pathol 18(2):144–150

    Article  CAS  PubMed  Google Scholar 

  • Shih IM, Kurman RJ (2001) The pathology of intermediate trophoblastic tumors and tumor-like lesions. Int J Gynecol Pathol 20(1):31–47

    Article  CAS  PubMed  Google Scholar 

  • Shih IM, Kurman RJ (2002) Molecular basis of gestational trophoblastic diseases. Curr Mol Med 2(1):1–12

    Article  CAS  PubMed  Google Scholar 

  • Shih IM, Kurman RJ (2004) p63 expression is useful in the distinction of epithelioid trophoblastic and placental site trophoblastic tumors by profiling trophoblastic subpopulations. Am J Surg Pathol 28(9):1177–1183

    Article  PubMed  Google Scholar 

  • Shih IM et al (1997) Distribution of cells bearing the HNK-1 epitope in the human placenta. Placenta 18(8):667–674

    Article  CAS  PubMed  Google Scholar 

  • Shih IM, Seidman JD, Kurman RJ (1999) Placental site nodule and characterization of distinctive types of intermediate trophoblast. Hum Pathol 30(6):687–694

    Article  CAS  PubMed  Google Scholar 

  • Shih IM et al (2002) The role of E-cadherin in the motility and invasion of implantation site intermediate trophoblast. Placenta 23(10):706–715

    Article  CAS  PubMed  Google Scholar 

  • Silva EG et al (1993) Multiple nodules of intermediate trophoblast following hydatidiform moles. Int J Gynecol Pathol 12(4):324–332

    Article  CAS  PubMed  Google Scholar 

  • Singer G et al (2002) HLA-G immunoreactivity is specific for intermediate trophoblast in gestational trophoblastic disease and can serve as a useful marker in differential diagnosis. Am J Surg Pathol 26(7):914–920

    Article  PubMed  Google Scholar 

  • Siu MKY et al (2008) Overexpression of Nanog in gestational trophoblastic diseases- effect on apoptosis, cell invasion and clinical outcome. Am J Pathol 173:1165

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  • Slim R, Mehio A (2007) The genetics of hydatidiform moles: new lights on an ancient disease. Clin Genet 71(1):25–34

    Article  CAS  PubMed  Google Scholar 

  • Soper JT (2006) Gestational trophoblastic disease. Obstet Gynecol 108(1):176–187

    Article  PubMed  Google Scholar 

  • Stichelbout M et al (2016) SALL4 expression in gestational trophoblastic tumors: a useful tool to distinguish choriocarcinoma from placental site trophoblastic tumor and epithelioid trophoblastic tumor. Hum Pathol 54:121–126

    Article  CAS  PubMed  Google Scholar 

  • Su YN et al (1999) Pregnancy with primary tubal placental site trophoblastic tumor – a case report and literature review. Gynecol Oncol 73(2):322–325

    Article  CAS  PubMed  Google Scholar 

  • Suzuki T et al (1993) Identification of the pregnancy responsible for gestational trophoblastic disease by DNA analysis. Obstet Gynecol 82(4 Pt 1):629–634

    CAS  PubMed  Google Scholar 

  • Szulman AE, Surti U (1982) The clinicopathologic profile of the partial hydatidiform mole. Obstet Gynecol 59(5):597–602

    CAS  PubMed  Google Scholar 

  • Traboulsi W et al (2017) Antagonism of EG-VEGF receptors as targeted therapy for choriocarcinoma progression in vitro and in vivo. Clin Cancer Res 23:7130

    Article  CAS  PubMed  Google Scholar 

  • Tsai HW et al (2008) Placental site nodule transformed into a malignant epithelioid trophoblastic tumour with pelvic lymph node and lung metastasis. Histopathology 53(5):601–604

    PubMed  Google Scholar 

  • Vang R et al (2012) Diagnostic reproducibility of hydatidiform moles: ancillary techniques (p57 immunohistochemistry and molecular genotyping) improve morphologic diagnosis. Am J Surg Pathol 36(3):443–453

    Article  PubMed  PubMed Central  Google Scholar 

  • Vencken PM, Ewing PC, Zweemer RP (2006) Epithelioid trophoblastic tumour: a case report and review of the literature. J Clin Pathol 59(12):1307–1308

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  • Veras E et al (2017) PD-L1 expression in human placentas and gestational trophoblastic diseases. Int J Gynecol Pathol 36(2):146–153

    CAS  PubMed  PubMed Central  Google Scholar 

  • Wells M (2007) The pathology of gestational trophoblastic disease: recent advances. Pathology 39(1):88–96

    Article  PubMed  Google Scholar 

  • Xu ML et al (2009) Epithelioid trophoblastic tumor: comparative genomic hybridization and diagnostic DNA genotyping. Mod Pathol 22(2):232–238

    Article  CAS  PubMed  Google Scholar 

  • Xue WC et al (2002) Malignant placental site trophoblastic tumor: a cytogenetic study using comparative genomic hybridization and chromosome in situ hybridization. Cancer 94(8):2288–2294

    Article  PubMed  Google Scholar 

  • Yap KL et al (2010) Lack of a y-chromosomal complement in the majority of gestational trophoblastic neoplasms. J Oncol 2010:364508

    Article  PubMed  PubMed Central  CAS  Google Scholar 

  • Young RH, Scully RE (1984) Placental-site trophoblastic tumor: current status. Clin Obstet Gynecol 27(1):248–258

    Article  CAS  PubMed  Google Scholar 

  • Yuan CC, Wang PH, Ng HT (1999) High hCG level is a risk factor for predicting the occurrence of brain and/or liver metastases from gestational choriocarcinoma. Int J Gynaecol Obstet 65(1):67–69

    Article  CAS  PubMed  Google Scholar 

  • Zalel Y, Dgani R (1997) Gestational trophoblastic disease following the evacuation of partial hydatidiform mole: a review of 66 cases. Eur J Obstet Gynecol Reprod Biol 71(1):67–71

    Article  CAS  PubMed  Google Scholar 

  • Zanetta G et al (1997) Choriocarcinoma coexistent with intrauterine pregnancy: two additional cases and a review of the literature. Int J Gynecol Cancer 7:66–77

    Article  CAS  PubMed  Google Scholar 

  • Zhang H-J et al (2009) P63 expression in gestational trophoblastic disease: correlation with proliferation and apoptotic dynamics. Int J Gynecol Pathol 28:172–178

    Article  PubMed  Google Scholar 

  • Zhao S et al (2016a) Molecular genotyping of placental site and epithelioid trophoblastic tumours; female predominance. Gynecol Oncol 142(3):501–507

    Article  CAS  PubMed  Google Scholar 

  • Zhao J et al (2016b) Placental site trophoblastic tumor: a review of 108 cases and their implications for prognosis and treatment. Gynecol Oncol 142(1):102–108

    Article  CAS  PubMed  Google Scholar 

  • Zhou Y et al (1997) Human cytotrophoblasts adopt a vascular phenotype as they differentiate: a strategy for successful endovascular invasion? J Clin Invest 99:2139–2151

    Article  CAS  PubMed  PubMed Central  Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Ie-Ming Shih .

Editor information

Editors and Affiliations

Rights and permissions

Reprints and permissions

Copyright information

© 2018 Springer Science+Business Media, LLC, part of Springer Nature

About this entry

Check for updates. Verify currency and authenticity via CrossMark

Cite this entry

Shih, IM., Ronnett, B.M., Mazur, M., Kurman, R.J. (2018). Gestational Trophoblastic Tumors and Related Tumorlike Lesions. In: Kurman, R., Hedrick Ellenson, L., Ronnett, B. (eds) Blaustein's Pathology of the Female Genital Tract. Springer, New York, NY. https://doi.org/10.1007/978-1-4614-3165-7_20-2

Download citation

  • DOI: https://doi.org/10.1007/978-1-4614-3165-7_20-2

  • Received:

  • Accepted:

  • Published:

  • Publisher Name: Springer, New York, NY

  • Print ISBN: 978-1-4614-3165-7

  • Online ISBN: 978-1-4614-3165-7

  • eBook Packages: Springer Reference MedicineReference Module Medicine

Publish with us

Policies and ethics